Alimera Sciences (ALIM) Reports Fourth Quarter And Full Year 2013 Financial Results
2/28/2014 6:22:45 AM
ATLANTA, Feb. 27, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced financial results for the fourth quarter and full year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by